COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN PORTUGAL

被引：0
|
作者：
Mateus, C. [1 ]
Moura, A. [1 ]
机构：
[1] Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2616
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS46
引用
收藏
页码：A380 / A381
页数：3
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN CHINA
    Zhang, Y.
    Yang, L.
    Dong, P.
    Xie, X.
    Tang, B.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A673 - A673
  • [2] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICO
    Vargas-Valencia, J.
    Sotelo-Guzman, M.
    Mould-Quevedo, J. F.
    Mucino-Ortega, E.
    Galindo-Suarez, R. M.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A127 - A127
  • [3] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN INSTITUTIONAL MARKET IN ECUADOR
    Albuja, M. F.
    Torres, F. G.
    Mould, J.
    Estevez, C.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A717 - A717
  • [4] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT AND INFLIXIMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN SPAIN
    Guijarro, P.
    Crespo, C.
    Brosa, M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A448 - A448
  • [5] Cost-effectiveness analysis of etanercept vs infliximab for treatment of severe rheumatoid arthritis in Brazil
    Saggia, M. G.
    Pina, F. P.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A220 - A220
  • [6] Cost-effectiveness analysis of etanercept versus infliximab and anakinra in the treatment of rheumatoid arthritis in italy.
    Leardini, G
    Ganguly, R
    Singh, A
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S460 - S461
  • [7] Cost-effectiveness of lifelong infliximab for rheumatoid arthritis in Portugal
    Wong, JB
    Branco, JC
    Cobrado, N
    Nero, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 360 - 360
  • [8] Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
    Gholami, Ahmad
    Azizpoor, Jassem
    Aflaki, Elham
    Rezaee, Mehdi
    Keshavarz, Khosro
    [J]. BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [9] COST-EFFECTIVENESS ANALYSIS OF GOLIMUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Desai, R. J.
    Rao, J.
    Biddle, A. K.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A39 - A39
  • [10] MODELLING THE COST-EFFECTIVENESS OF ETANERCEPT IN ADULTS WITH RHEUMATOID ARTHRITIS IN THE UK
    Brennan, A.
    Bansback, N.
    Conway, P.
    Reynolds, A.
    [J]. RHEUMATOLOGY, 2002, 41 : 91 - 91
12345